ASH: Rituximab add-on therapy ‘new standard’ in BCP-ALLDecember 7, 2015Leukemia, Myelodysplasia, Transplantation
VIDEO: Midostaurin hits mark in FLT3-mutated AMLDecember 7, 2015Leukemia, Myelodysplasia, Transplantation
ASH: Genes tag increased risk for avascular necrosis in ALL patients under age 10December 6, 2015Leukemia, Myelodysplasia, Transplantation
ASH: Pill bottles flag noncompliance in patients on ALL maintenanceDecember 6, 2015Leukemia, Myelodysplasia, Transplantation
ASH: Genes, induction response identify high risk childhood B-lymphoblastic leukemia patients with good outcomesDecember 5, 2015Leukemia, Myelodysplasia, Transplantation
ASH: Donor CAR-T cells elicit responses in mixture of progressive B-cell cancersDecember 5, 2015Leukemia, Myelodysplasia, Transplantation
Expert panel issues guidelines for treatment of hematologic cancers in pregnancyDecember 1, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
Ixazomib approved for multiple myeloma combo treatmentNovember 20, 2015Leukemia, Myelodysplasia, Transplantation
NCCN unveils 'Evidence Blocks' to facilitate treatment discussionsOctober 23, 2015Leukemia, Myelodysplasia, TransplantationPatient & Survivor Care
Emerging evidence is resolving questions in CML managementOctober 23, 2015Leukemia, Myelodysplasia, Transplantation
In ALL, early treatment decisions have “irrevocable” implicationsOctober 17, 2015Leukemia, Myelodysplasia, Transplantation
CML: Select TKI based on comorbidities, monitor toxicity and adherenceOctober 14, 2015Leukemia, Myelodysplasia, Transplantation
Five epigenetic biomarkers define three CLL subgroupsOctober 13, 2015Leukemia, Myelodysplasia, Transplantation
IgA increase linked to fewer infections in CLL patients on ibrutinibOctober 8, 2015Leukemia, Myelodysplasia, Transplantation
